GHK-Cu inflammaging
Physicians who were familiar with peptide therapy as recently as 2022 may be working from outdated information about legal availability
Black shank resistant tobacco by silencing of glutathione S-transferase [PMID: 19577539] Laboratory literature summary: Black shank resistant tobacco by silencing of glutathione S-transferase
Each peptide in the formulation has an established safety profile with minimal side effects
Abbreviations AD: Alzheimers disease ANS: Autonomic nervous system BBB: Blood brain barrier CNS: Central nervous system GABA: Gamma aminobutyric acid NF-B: Nuclear factor kappa B NLRP3: Nod-like receptor pyrin 3 PD: Parkinsons disease ROS: Reactive oxygen species SAH: S-adenosyl-homocysteine SN: Substantia nigra References Aborode AT, Pustake M, Awuah WA, Alwerdani M, Shah P, Yarlagadda R, Ahmad S, Silva Correia IF, Chandra A, Nansubuga EP, Abdul-Rahman T, Mehta A, Ali O, Amaka SO, Zuiga YMH, Shkodina AD, Inya OC, Shen B, Alexiou A (2022) Targeting oxidative stress mechanisms to treat alzheimers and parkinsons disease: a critical review
The experimental setup involved exposure of dermal fibroblasts with various combinations of GHK-Cu and HA, measuring the synthesis of collagen types I, IV, and VII
